Allergan

Allergan's Vraylar launch a success, despite trial failure
BioPharma Dive
Tue, 08/9/16 - 10:40 am
Allergan
Vraylar
drug launches
clinical trials
antipsychotics
Geodon Richter
Allergan revenue disappoints as Alzheimer drug loses exclusivity
Yahoo/Reuters
Mon, 08/8/16 - 10:04 am
Allergan
earnings
Namenda XR
Business groups sue U.S. gov over tax rules that spoiled 'Pfizergan'
Fierce Pharma
Mon, 08/8/16 - 10:00 am
taxes
Pfizer
Allergan
M&A
Allergan's cash-use plan, pipeline could add to share run
Yahoo/Reuters
Thu, 08/4/16 - 09:18 pm
Allergan
Will Merck Pay A 29% Premium for Biogen?
Forbes
Thu, 08/4/16 - 10:02 am
Biogen
Merck
Allergan
M&A
Teva Pharm to focus on integrating Allergan's generics business
Yahoo/Reuters
Thu, 08/4/16 - 09:57 am
Teva Pharmaceuticals
generics
M&A
Allergan
Biogen: Allergan or Merck? Neither
Barron's
Thu, 08/4/16 - 09:49 am
Biogen
M&A
Merck
Allergan
Teva to buy Allergan's Anda Inc. distribution business for $500 mln
Marketwatch
Wed, 08/3/16 - 09:22 am
Teva Pharmaceutical
Anda
Allergan
M&A
Merck and Allergan have both expressed interest in a Biogen takeover
Marketwatch
Tue, 08/2/16 - 03:12 pm
Merck
Allergan
Biogen
M&A
Ex-Allergan CEO David Pyott backs a biotech startup alongside Takeda, PhI trial set to launch
Endpoints
Mon, 08/1/16 - 09:44 am
Allergan
David Pyott
biotech
Takeda
Bioniz
peptide platform
The Shire Vs. Allergan War Has Begun
Seeking Alpha
Mon, 08/1/16 - 09:39 am
Shire
Allergan
dry eye disease
Xiidra
Restasis
FTC Clears Teva Pharmaceutical Industries-Allergan plc Generics Deal; What's Next?
Bidness, ETC
Sat, 07/30/16 - 09:45 pm
FTC
Teva Pharmaceuticals
Allergan
generics
Shire targets Allergan's dry-eye market share by pricing Xiidra at $5K per year--right on par with Restasis
Fierce Pharma
Tue, 07/26/16 - 11:25 am
dry eye disease
Shire
Allergan
Xiidra
Restasis
Six Major Biotech Acquisitions You Could See in 2016 (Part 2)
Forbes
Mon, 07/25/16 - 09:51 am
biotech
M&A
Pfizer
Teva Pharmaceutical
Allergan
Shire
Portola Pharmaceuticals
Sanofi
Medivation
Regeneron
Biogen
Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin
WSJ Online
Fri, 07/22/16 - 09:49 am
Amgen
Allergan
biosimilars
Herceptin
ABP 980
Roche
breast cancer
Allergan asks FDA to approve Oculeve neurostim device
Mass Device
Mon, 07/18/16 - 11:03 am
Allergan
FDA
Oculeve
neurostimulation
devices
Why Allergan thinks an 'open science' approach can help it develop new antibiotics
BioPharma Dive
Fri, 07/15/16 - 10:16 am
Allergan
R&D
antibiotics
open science
Teva, Allergan generics deal to close 'at any time now'
BioPharma Dive
Thu, 07/14/16 - 10:08 am
Teva Pharmaceutical
generics
M&A
Allergan
Teva Pharm to raise $20-$25 bln in bond sale next week -report
Yahoo/Reuters
Thu, 07/14/16 - 09:13 am
Teva Pharmaceutical
Allergan
M&A
generics
bonds
Should Allergan Worry About Shire’s Win With Dry Eye Drug?
Bidness, ETC
Wed, 07/13/16 - 11:02 am
Allergan
Shire
dry eye disease
Restasis
Xiidra

Pages